Glenmark to bring into India, two cancer drugs from BeiGene
Glenmark Specialty SA partners with BeiGene to bring innovative oncology drugs to India, addressing rising cancer rates.
Source: thehindubusinessline.com
India Formulations News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from India Formulations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In India Formulations Today - Breaking & Trending Today
Glenmark partners with Pfizer to launch abrocitinib in India to treat atopic dermatitis
Glenmark and Pfizer will co-market abrocitinib in India under the brand names JABRYUS and CIBINQO. Developed by Pfizer, abrocitinib has received marketing authorization for abrocitinib in adults with moderate-to-severe atopic dermatitis from the Central Drugs Standard Control Organization (CDSCO). It is also approved by the USFDA, European Medicines Agency (EMA), and other regulatory agencies.
Source: indiatimes.com
Pfizer and Glenmark partner to introduce novel atopic dermatitis treatment in India
Atopic dermatitis is a debilitating form of chronic skin inflammation, characterised by severe itching and skin lesions
Source: businesstoday.in
Glenmark Pharma launches antidiabetic injectable
India Business News: Glenmark Pharmaceuticals has launched the first biosimilar of the popular anti-diabetic drug, Liraglutide in India. The drug, marketed as Lirafit, is
Source: indiatimes.com
Glenmark launches diabetes drug combination for adults with co-morbidities
This drug assists in the enhancement of glycemic regulation in adult patients who have a high level of hyperbolic acid (HBA1c) and/or are co-infected with other conditions. It will be priced at Rs 14 per tablet (per day).
Source: moneycontrol.com